0001104659-23-122895.txt : 20231201 0001104659-23-122895.hdr.sgml : 20231201 20231201171455 ACCESSION NUMBER: 0001104659-23-122895 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231129 FILED AS OF DATE: 20231201 DATE AS OF CHANGE: 20231201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wedell-Wedellsborg Johan CENTRAL INDEX KEY: 0001753185 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38650 FILM NUMBER: 231460477 MAIL ADDRESS: STREET 1: RUNGSTED STRANDVEJ 113 CITY: RUNGSTED KYST STATE: G7 ZIP: 2960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc. CENTRAL INDEX KEY: 0001722964 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474619612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: 212-847-9841 MAIL ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 4 1 tm2330155d7_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-11-29 0 0001722964 Y-mAbs Therapeutics, Inc. YMAB 0001753185 Wedell-Wedellsborg Johan C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, SUITE 3350 NEW YORK NY 10169 1 0 0 0 0 Common Stock 2023-11-29 4 P 0 51837 5.9702 A 4425229 I By WG Biotech ApS This transaction was executed in multiple trades at prices ranging from $5.82 to $6.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares. /s/ Johan Wedell-Wedellsborg 2023-12-01